cyclosporine

Translating Psoriasis Guidelines into Practice
psoriasis guidelines
by Mojgan Hosseinipour, DO, FAAD on
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection. The International Psoriasis Council has divided psoriasis treatment classification into 2 groups: Patients who are a candidate for topical therapy, or Patients who are a candidate for systemic therapy Candidates for systemic therapy must meet at least 1 of the following …

Continue reading "Translating Psoriasis Guidelines into Practice"

Atopic Dermatitis (AD) Treatment Initiation and Monitoring
atopic dermatitis (AD)
by Mojgan Hosseinipour, DO, FAAD on
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.  CASE 1 51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA …

Continue reading "Atopic Dermatitis (AD) Treatment Initiation and Monitoring"

The Many Faces of Psoriasis | Part 2
psoriasis
by Lauren C. Payne, MD, MS, FAAD on
Did you know that psoriasis doesn’t just present on the arms, legs, and trunk? It can also appear in non-conventional locations (aka “special site” psoriasis) including the scalp, face, and body folds (such as the axillary, inframammary, and inguinal fields, and intergluteal clefts). In the skin folds, psoriasis is also referred to as “inverse psoriasis.” In darker skin types, the areas …

Continue reading "The Many Faces of Psoriasis | Part 2"

Tralokinumab-ldrm Therapeutic Cheat Sheet
tralokinumab
by Emily Murphy, MD on
Atopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c …

Continue reading "Tralokinumab-ldrm Therapeutic Cheat Sheet"

Oral Glucocorticoids for Psoriasis? The Expert Weighs In
Glucocorticoids
by Allison Sit on
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh …

Continue reading "Oral Glucocorticoids for Psoriasis? The Expert Weighs In"